Literature DB >> 6802160

The effect of acebutolol and propranolol on the hypoglycaemic action of glibenclamide.

R Zaman, M J Kendall, P I Biggs.   

Abstract

1 The effect of acebutolol, a relatively selective beta-adrenoceptor blocking drug and propranolol, a non-selective one, on the hypoglycaemic action of glibenclamide after an oral glucose load has been investigated in a group of maturity-onset diabetic patients. 2 Glibenclamide significantly reduced the blood glucose levels and both acebutolol and propranolol, at therapeutic doses, were found to modify this action significantly. 3 The effect of acebutolol was slightly less than that of propranolol. The difference was not statistically significant. 4 The modes of action of sulphonylureas are reviewed and it is suggested that beta-adrenoceptor blockers may modify their effect on insulin release. This appears to be a drug interaction rather than an effect of beta-adrenoceptor blockade on glucose tolerance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802160      PMCID: PMC1402050          DOI: 10.1111/j.1365-2125.1982.tb01412.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  23 in total

1.  High-pressure liquid chromatographic analysis of drugs in biological fluids. V. Analysis of acebutolol and its major metabolite.

Authors:  P J Meffin; S R Harapat; Y G Yee; D C Harrison
Journal:  J Chromatogr       Date:  1977-08-01

2.  The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor.

Authors:  A Loubatières; M M Mariani; G Sorel; L Savi
Journal:  Diabetologia       Date:  1971-06       Impact factor: 10.122

3.  Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.

Authors:  A J Barnes; K J Garbien; M F Crowley; A Bloom
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

4.  Tolbutamide and propranolol.

Authors:  O De Divitiis; F Giordano; B Gallo; A Jacono
Journal:  Lancet       Date:  1968-04-06       Impact factor: 79.321

5.  Metabolic and clinical effects of glibenclamide.

Authors:  M Davidson; A A Lewis; R R De Mowbray; B J Boucher; N W Oakley; J D Nabarro; J Ginsburg; P Beaconsfield
Journal:  Lancet       Date:  1970-01-10       Impact factor: 79.321

Review 6.  Appraisal of the extrapancreatic actions of sulfonylureas.

Authors:  J M Feldman; H E Lebovitz
Journal:  Arch Intern Med       Date:  1969-03

7.  Effect of chlorpropamide treatment on insulin secretion in diabetics: its relationship to the hypoglycemic effect.

Authors:  A Hecht; H Gershberg; M Hulse
Journal:  Metabolism       Date:  1973-05       Impact factor: 8.694

8.  Depressed tolbutamide-induced insulin response in subjects treated with propranolol.

Authors:  F Massara; E Strumia; F Camanni; G M Molinatti
Journal:  Diabetologia       Date:  1971-08       Impact factor: 10.122

9.  Inhibition of sulphonylurea-stimulated insulin secretion by beta adrenergic blockage.

Authors:  O V Sirek; Z Sirek; Z Policova
Journal:  Diabetologia       Date:  1975-08       Impact factor: 10.122

10.  Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide.

Authors:  G M Shenfield; A Logan; D Shirling; J Baird
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

View more
  5 in total

Review 1.  Required beta blocker profile in the elderly.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

2.  Betaxolol and glucose-insulin relationships: studies in normal subjects taking glibenclamide or metformin.

Authors:  A J Sinclair; I B Davies; S J Warrington
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

Review 3.  Pharmacotherapy of type 2 diabetes mellitus: an update on drug-drug interactions.

Authors:  Muhammad Amin; Naeti Suksomboon
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

Review 4.  Antihyperglycaemic agents. Drug interactions of clinical importance.

Authors:  A J Scheen; P J Lefèbvre
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

Review 5.  Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

Authors:  A Melander; P O Bitzén; O Faber; L Groop
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.